ID   CHKB_HUMAN              Reviewed;         395 AA.
AC   Q9Y259; A0PJM6; Q13388;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   15-MAR-2017, entry version 142.
DE   RecName: Full=Choline/ethanolamine kinase;
DE   AltName: Full=Choline kinase beta;
DE            Short=CK;
DE            Short=CKB;
DE            EC=2.7.1.32;
DE   AltName: Full=Choline kinase-like protein;
DE   AltName: Full=Ethanolamine kinase;
DE            Short=EK;
DE            EC=2.7.1.82;
DE   AltName: Full=Ethanolamine kinase beta;
DE            Short=EKB;
DE   AltName: Full=choline/ethanolamine kinase beta;
DE            Short=CKEKB;
GN   Name=CHKB; Synonyms=CHETK, CHKL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=10918069; DOI=10.1074/jbc.M006322200;
RA   Yamazaki N., Shinohara Y., Kajimoto K., Shindo M., Terada H.;
RT   "Novel expression of equivocal messages containing both regions of
RT   choline/ethanolamine kinase and muscle type carnitine
RT   palmitoyltransferase I.";
RL   J. Biol. Chem. 275:31739-31746(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Smink L.J., Huckle E.J.;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-19, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=T-cell;
RA   Bienvenut W.V., Kanor S., Tissot J.-D., Quadroni M.;
RL   Submitted (MAY-2006) to UniProtKB.
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19915674; DOI=10.1371/journal.pone.0007819;
RA   Gallego-Ortega D., Ramirez de Molina A., Ramos M.A., Valdes-Mora F.,
RA   Barderas M.G., Sarmentero-Estrada J., Lacal J.C.;
RT   "Differential role of human choline kinase alpha and beta enzymes in
RT   lipid metabolism: implications in cancer onset and treatment.";
RL   PLoS ONE 4:E7819-E7819(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 14-395 IN COMPLEX WITH ADP;
RP   MAGNESIUM IONS AND HEMICHOLINIUM-3.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human choline kinase beta in complex with
RT   phosphorylated hemicholinium-3 and adenosine nucleotide.";
RL   Submitted (SEP-2009) to the PDB data bank.
CC   -!- FUNCTION: Has a key role in phospholipid biosynthesis. Catalyzes
CC       the first step in phosphatidylethanolamine biosynthesis.
CC       Phosphorylates ethanolamine, and can also act on choline (in
CC       vitro). Has higher activity with ethanolamine. May not
CC       significantly contribute to in vivo phosphatidylcholine
CC       biosynthesis. {ECO:0000269|PubMed:19915674}.
CC   -!- CATALYTIC ACTIVITY: ATP + choline = ADP + phosphocholine.
CC       {ECO:0000269|PubMed:19915674}.
CC   -!- CATALYTIC ACTIVITY: ATP + ethanolamine = ADP + O-
CC       phosphoethanolamine. {ECO:0000269|PubMed:19915674}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.57 mM for choline {ECO:0000269|PubMed:19915674};
CC         KM=2.9 mM for ethanolamine {ECO:0000269|PubMed:19915674};
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylethanolamine
CC       biosynthesis; phosphatidylethanolamine from ethanolamine: step
CC       1/3.
CC   -!- SUBUNIT: Homodimer, and heterodimer with CHKA.
CC       {ECO:0000269|Ref.11}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y259-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y259-2; Sequence=VSP_034248, VSP_034249;
CC   -!- MISCELLANEOUS: This protein is produced by a bicistronic gene
CC       which also produces the CPT1B protein from a non-overlapping
CC       reading frame.
CC   -!- SIMILARITY: Belongs to the choline/ethanolamine kinase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB03342.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB029885; BAA82511.1; -; Genomic_DNA.
DR   EMBL; AB029886; BAA82512.1; -; mRNA.
DR   EMBL; AL096780; CAB46629.1; -; mRNA.
DR   EMBL; AL096781; CAB46630.1; -; mRNA.
DR   EMBL; CR456419; CAG30305.1; -; mRNA.
DR   EMBL; AK314324; BAG36972.1; -; mRNA.
DR   EMBL; U62317; AAB03342.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471138; EAW73573.1; -; Genomic_DNA.
DR   EMBL; BC082263; AAH82263.1; -; mRNA.
DR   EMBL; BC101488; AAI01489.1; -; mRNA.
DR   EMBL; BC113521; AAI13522.2; -; mRNA.
DR   CCDS; CCDS14099.1; -. [Q9Y259-1]
DR   RefSeq; NP_005189.2; NM_005198.4. [Q9Y259-1]
DR   UniGene; Hs.654827; -.
DR   PDB; 2IG7; X-ray; 1.80 A; A/B=14-395.
DR   PDB; 3FEG; X-ray; 1.30 A; A=35-395.
DR   PDB; 3LQ3; X-ray; 1.42 A; A=14-395.
DR   PDBsum; 2IG7; -.
DR   PDBsum; 3FEG; -.
DR   PDBsum; 3LQ3; -.
DR   ProteinModelPortal; Q9Y259; -.
DR   SMR; Q9Y259; -.
DR   BioGrid; 107544; 1.
DR   IntAct; Q9Y259; 1.
DR   STRING; 9606.ENSP00000384400; -.
DR   BindingDB; Q9Y259; -.
DR   ChEMBL; CHEMBL3112385; -.
DR   DrugBank; DB00122; Choline.
DR   iPTMnet; Q9Y259; -.
DR   PhosphoSitePlus; Q9Y259; -.
DR   BioMuta; CHKB; -.
DR   DMDM; 6685604; -.
DR   EPD; Q9Y259; -.
DR   PaxDb; Q9Y259; -.
DR   PeptideAtlas; Q9Y259; -.
DR   PRIDE; Q9Y259; -.
DR   DNASU; 1120; -.
DR   Ensembl; ENST00000406938; ENSP00000384400; ENSG00000100288. [Q9Y259-1]
DR   GeneID; 1120; -.
DR   KEGG; hsa:1120; -.
DR   UCSC; uc003bmv.4; human. [Q9Y259-1]
DR   CTD; 1120; -.
DR   DisGeNET; 1120; -.
DR   GeneCards; CHKB; -.
DR   GeneReviews; CHKB; -.
DR   HGNC; HGNC:1938; CHKB.
DR   HPA; HPA018797; -.
DR   MalaCards; CHKB; -.
DR   MIM; 612395; gene.
DR   neXtProt; NX_Q9Y259; -.
DR   OpenTargets; ENSG00000100288; -.
DR   Orphanet; 280671; Congenital muscular dystrophy due to phosphatidylcholine biosynthesis defect.
DR   PharmGKB; PA26469; -.
DR   eggNOG; KOG2686; Eukaryota.
DR   eggNOG; COG0510; LUCA.
DR   GeneTree; ENSGT00530000062991; -.
DR   HOGENOM; HOG000041274; -.
DR   HOVERGEN; HBG050943; -.
DR   InParanoid; Q9Y259; -.
DR   KO; K14156; -.
DR   OMA; YKAQPAN; -.
DR   OrthoDB; EOG091G06UK; -.
DR   PhylomeDB; Q9Y259; -.
DR   TreeFam; TF313549; -.
DR   BRENDA; 2.7.1.32; 2681.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   Reactome; R-HSA-1483213; Synthesis of PE.
DR   SABIO-RK; Q9Y259; -.
DR   UniPathway; UPA00558; UER00741.
DR   EvolutionaryTrace; Q9Y259; -.
DR   GeneWiki; CHKB_(gene); -.
DR   GenomeRNAi; 1120; -.
DR   PRO; PR:Q9Y259; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100288; -.
DR   CleanEx; HS_CHKB; -.
DR   ExpressionAtlas; Q9Y259; baseline and differential.
DR   Genevisible; Q9Y259; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004103; F:choline kinase activity; IDA:UniProtKB.
DR   GO; GO:0004305; F:ethanolamine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome.
DR   GO; GO:0006646; P:phosphatidylethanolamine biosynthetic process; IDA:UniProtKB.
DR   InterPro; IPR026712; Cho/Etha_kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   PANTHER; PTHR22603:SF54; PTHR22603:SF54; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Direct protein sequencing; Kinase;
KW   Lipid biosynthesis; Lipid metabolism; Nucleotide-binding;
KW   Phospholipid biosynthesis; Phospholipid metabolism;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.8}.
FT   CHAIN         2    395       Choline/ethanolamine kinase.
FT                                /FTId=PRO_0000206222.
FT   NP_BIND      75     81       ATP. {ECO:0000250}.
FT   NP_BIND     146    152       ATP.
FT   REGION       77     79       Substrate binding. {ECO:0000250}.
FT   BINDING     104    104       ATP.
FT   BINDING     244    244       ATP. {ECO:0000250}.
FT   BINDING     264    264       ATP.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.8}.
FT   VAR_SEQ      75    127       SGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDS
FT                                LVLESVMFAILA -> RWEVRGQPLRCADRGQGSAAGPSGC
FT                                SMFSPPSCARAWGGAGPAWPGGGRGRGR (in isoform
FT                                2). {ECO:0000305}.
FT                                /FTId=VSP_034248.
FT   VAR_SEQ     128    395       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_034249.
FT   HELIX        43     57       {ECO:0000244|PDB:3FEG}.
FT   HELIX        59     63       {ECO:0000244|PDB:3FEG}.
FT   HELIX        66     68       {ECO:0000244|PDB:3FEG}.
FT   STRAND       70     74       {ECO:0000244|PDB:2IG7}.
FT   TURN         77     79       {ECO:0000244|PDB:2IG7}.
FT   STRAND       82     86       {ECO:0000244|PDB:3FEG}.
FT   STRAND       94     96       {ECO:0000244|PDB:2IG7}.
FT   STRAND       99    105       {ECO:0000244|PDB:3FEG}.
FT   HELIX       108    110       {ECO:0000244|PDB:2IG7}.
FT   HELIX       113    128       {ECO:0000244|PDB:3FEG}.
FT   STRAND      135    139       {ECO:0000244|PDB:3FEG}.
FT   STRAND      142    146       {ECO:0000244|PDB:3FEG}.
FT   STRAND      149    152       {ECO:0000244|PDB:3FEG}.
FT   HELIX       155    159       {ECO:0000244|PDB:3FEG}.
FT   HELIX       161    175       {ECO:0000244|PDB:3FEG}.
FT   HELIX       187    201       {ECO:0000244|PDB:3FEG}.
FT   HELIX       212    215       {ECO:0000244|PDB:3FEG}.
FT   HELIX       218    230       {ECO:0000244|PDB:3FEG}.
FT   STRAND      236    239       {ECO:0000244|PDB:3FEG}.
FT   HELIX       245    247       {ECO:0000244|PDB:3FEG}.
FT   STRAND      248    252       {ECO:0000244|PDB:3FEG}.
FT   STRAND      255    257       {ECO:0000244|PDB:2IG7}.
FT   STRAND      260    262       {ECO:0000244|PDB:3FEG}.
FT   HELIX       265    267       {ECO:0000244|PDB:2IG7}.
FT   STRAND      269    272       {ECO:0000244|PDB:3FEG}.
FT   HELIX       273    283       {ECO:0000244|PDB:3FEG}.
FT   HELIX       300    302       {ECO:0000244|PDB:3FEG}.
FT   HELIX       306    320       {ECO:0000244|PDB:3FEG}.
FT   TURN        321    323       {ECO:0000244|PDB:3FEG}.
FT   HELIX       328    361       {ECO:0000244|PDB:3FEG}.
FT   STRAND      365    368       {ECO:0000244|PDB:3FEG}.
FT   HELIX       370    386       {ECO:0000244|PDB:3FEG}.
SQ   SEQUENCE   395 AA;  45271 MW;  18367468B22FB9CE CRC64;
     MAAEATAVAG SGAVGGCLAK DGLQQSKCPD TTPKRRRASS LSRDAERRAY QWCREYLGGA
     WRRVQPEELR VYPVSGGLSN LLFRCSLPDH LPSVGEEPRE VLLRLYGAIL QGVDSLVLES
     VMFAILAERS LGPQLYGVFP EGRLEQYIPS RPLKTQELRE PVLSAAIATK MAQFHGMEMP
     FTKEPHWLFG TMERYLKQIQ DLPPTGLPEM NLLEMYSLKD EMGNLRKLLE STPSPVVFCH
     NDIQEGNILL LSEPENADSL MLVDFEYSSY NYRGFDIGNH FCEWVYDYTH EEWPFYKARP
     TDYPTQEQQL HFIRHYLAEA KKGETLSQEE QRKLEEDLLV EVSRYALASH FFWGLWSILQ
     ASMSTIEFGY LDYAQSRFQF YFQQKGQLTS VHSSS
//
